2Huang YS Genetic polymorphisms of drug-metabolizing enzymes and the susceptibility to antituberculosis drug-induced liver injury 2007(01):34-35.
3Xinhui Tang,Jing Gao,Yanping Wang.Effective protection of Terminalia catappa L.leaves from damage-induced by carbon tetrachloride in liver mitochondria[J].Journal of Nutritional Biochemistry,2006,17(3):177.
5Xin Hui Tang,Jing Gao,Feng Fang.Hepatoprotection of oleanolic acid is related to its inhibition on mitochondrial permeability transition[J].American Journal of Chin Med,2005,33(4):627.
3Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis, 2002, 22: 145-155.
4Amacher DE. Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul Toxicol Pharmacol, 1998, 27:119-130.
5Andrade RJ, Lucena MI, Pachkoria K, et al. Chronic liver damage after an episode of idiosyncratic drug induced liver injury (DILI). J Hepatol, 2006, 44(suppl 2):S247.
6Nathwani RA, Kaplowitz N. Drug hepatotoxicity. Clin Liver Dis, 2006, 10:207-217.
7Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol, 1990, 11 : 272-276
8Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf, 2007, 30:277-294.
9Temple R. Hy's law: predicting serious hepatotoxicity. Pharmaco epidemiol Drug Saf, 2006, 15 : 241-243.
10Poison J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology, 2005, 41 : 1179-1197.
